Ibogaine and the dopaminergic response to nicotine

Psychopharmacology

Volumn 129, Issue 3, 1997, Pages 249-256

  Maisonneuve, I M ^a   Mann, G L ^a   Deibel, C R ^a   Glick, S D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Acute tolerance; Dopamine; Ibogaine; In vivo; Microdialysis; Nicotine; Rat

Indexed keywords

ALKALOID; DOPAMINE; IBOGAINE; MECAMYLAMINE; NICOTINE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ANTAGONISM; DRUG INFUSION; DRUG TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; HOMOVANILLIC ACID; IBOGAINE; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0031045637     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050187     Document Type: Article

References (66)

1. 3H]-Mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues. Biochem Pharmacol 40:2105-2110
2. Benwell MEM, Balfour DJK (1992) The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105:849-856
3. Benwell MEM, Balfour DJK, Birrell CE (1995) Desensitization of the nicotine-induced mesolimbie dopamine responses during constant infusion with nicotine. Br J Pharmacol 114: 454-460
4. Benwell MEM, Holtom PE, Moran RJ, Balfour DJK (1996) Neurochemical and behavioural interactions between ibogaine and nicotine in the rat. Br J Pharmacol 117:743-749
5. Blomqvist O, Engel JA, Nissbrandt H, Söderpalm B (1993) The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. Eur J Pharmacol 249:207-213
6. Boksa P, Livett BG (1984) Desensitization to nicotinic cholinergic agonists and K+, agents that stimulate catecholamine secretion, in isolated adrenal chromaffin cells. J Neurochem 42: 607-617
7. Brazell MP, Mitchell SN, Joseph MH, Gray JA (1990) Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylaectic acid and ascorbic acid preferentially in the nucleus aecumbens of the rat: comparison with caudate-putamen. Neuropharmacology 29: 1177-1185
8. Briggs CA, McKenna DG (1996) Effect of MK-801 at the human α7 nicotinie acetylcholine receptor. Neuropharmacology 35: 407-414
9. Bullock AE, Barke KE, Schneider AS (1994) Nicotine tolerance in chromaffin cell cultures: acute and chronic exposure to smoking-related nicotine doses. J Neurochem 62:1863-1869
10. 45Ca2(+)-uptake into cultured bovine adrenal medullary cells. Biochem Pharmacol 41:715-722
11. Cappendijk SET, Dzoljie MR (1993) Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur J Pharmacol 241: 261-265
12. Carr LA, Rowell PP, Pierce WM Jr (1989) Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat. Neurochem Res 14:511-515
13. Chen K, Kokate TG, Donevan SD, Carroll I, Rogawski MA (1996) Ibogaine block of the NMDA receptor: in vitro and in vivo studies. Neuropharmacology 35:423-431
14. Chu B, Anantharam V, Treistman SN (1995) Ethanol inhibition of recombinant heteromeric NMDA channels in the presence and absence of modulators. J Neurochem 65:140-148
15. Clarke PB, Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358
16. Clarke PB, Chaudieu I, El-Bizri H, Boksa P, Quik M, Esplin BA, Capek R (1994) The pharmacology of the nicotinie antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. Br J Pharmacol 111:397-405
17. Corrigall WA, Coen KM (1991) Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104: 171-176
18. Corrigall WA, Franklin KB, Coen KM. Clarke PB (1992) The mesolimbic dopaminergic system is implicated in the reinforeing effects of nicotine. Psychopharmacology 107:285-289
19. Corrigall WA, Coen KM, Adamson KL (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284
20. Damsma G, Day J, Fibiger HC (1989) Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur J Pharmacol 168:363-368
21. Deecher DC, Teitler M, Soderlund DM, Bornmann WG, Kuehne ME, Glick SD (1992) Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Res 571:242-247
22. Deneris ES, Connolly J, Rogers SW, Duvoisin R (1991) Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors (Review). Trends Pharmacol Sci 12: 34-40
23. Dhahir HI (1971) A comparative study of the toxicity of ibogaine and serotonin. Doctoral thesis, Ann Harbor, Mich., USA, University Microfilm International, 71 325-341
24. French ED, Mura A, Wang T (1993) MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat AlO dopamine neurons: comparison to competitive NMDA antagonists. Synapse 13:108-116
25. Gallagher CA, Hough LB, Keefner SM, Seyed-Mozaffari A, Archer S, Glick SD (1995) Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry. Biochem Pharmacol 49:73-79
26. Glick SD, Rossman K, Steindorf S, Maisonneuve IM, Carlson JN (1991) Effects and aftereffects of ibogaine on morphine self-administration in rats. Eur J Pharmacol 195:341-345
27. Glick SD, Rossman K, Wang S, Dong N, Keller RW Jr (1993) Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with D-amphetamine. Brain Res 628:201-208
28. Glick SD, Kuehne ME, Raucci J, Wilson TE, Larson D, Keller RW Jr, Carlson JN (1994) Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Brain Res 657:14-22
29. 3H]dopamine release from mouse striatal synaptosomes. J Neurochem 62:1390-1398
30. Grenhoff J, Aston-Jones G, Svenson TH (1986) Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128:351-358
31. Gupta SK, Hwang SS, Causey D, Rolf CN, Gorsline J (1995) Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking. J Clin Pharmacol 35:985-989
32. Hakan RL, Ksir C (1991) Acute tolerance to the locomotor stimulant effects of nicotine in the rat. Psychopharmacology 104: 386-390
33. Hough LB, Pearl SM, Glick SD (1996) Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration. Life Sci 58:PL119-122
34. Imperato A, Mulas A, Di Chiara G (1986) Nicotine preferentially stimulates dopamine in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338
35. 3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels. Mol Pharmacol 35:387-393
36. 1 receptor and is dependent on NMDA stimulation. Mol Brain Res 23:1-13
37. Kumakura K, Karoum F, Guidotti A, Costa E (1980) Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells. Nature 283:489-492
38. Lapin EP, Maker HS, Bhardwaj A (1995) Ethanol enhancement of the motor-stimulating effect of nicotine in the rat. Alcohol 12: 217-220
39. Lester RAJ, Dani JA (1995) Acetylcholine receptor desensitization induced by nicotine in rat medial habenula neurons. J Neurophysiol 74:195-206
40. Lotsof HS (1985) Rapid method for interrupting the narcotic addiction syndrome. US Patent no. 4,499,096
41. Lotsof HS (1986) Rapid method for interrupting the cocaine and amphetamine abuse syndrome. US Patent no. 4,587,243
42. Lotsof HS (1989) Rapid method for attenuating the alcohol dependency syndrome. US Patent no. 4,857,523
43. Lotsof HS (1991) Rapid method for interrupting or attenuating the nicotine/tobacco dependency syndrome. US Patent no. 5,026,697
44. Maisonneuve IM, Keller RW Jr, Glick SD (1991) Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. Eur J Pharmacol 199: 35-42
45. Maisonneuve IM, Glick SD (1992) Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior. Eur J Pharmacol 212:263-266
46. Maisonneuve IM, Keller RW Jr, Glick SD (1992) Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in rats. Brain Res 579:87-92
47. Marley PD (1988) Desensitization of the nicotinic secretory response of adrenal chromaffin cells. Trends Pharmacol Sci 9:102-107
48. Mash DC, Staley JK, Baumann MH, Rothman RB, Hearn WL (1995a) Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sci 57:PL45-PL50
49. Mash DC, Staley JK, Pablo JP, Holohean AM, Hackman JC, Davidoff RA (1995b) Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neurosci Lett 192:53-56
50. Mifsud JC, Hernandez L, Hocbel BG (1989) Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 478:365-367
51. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors (see comments). Science 269:1692-1696
52. Miller RP, Rotenberg KS, Adir J (1977) Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. Drug Metab Dispos 5:436-443
53. Nisell M, Nomikos GG, Svensson TH (1994) Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 75:348-352
54. Ochoa EL, Chattopadhyay A, McNamee MG (1989) Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators. Cell Mol Neurobiol 9:141-178
55. O'Dell TJ, Christensen BN (1988) Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate- and aspartateinduced currents in horizontal cells dissociated from the catfish retina. Neurosci Lett 94:93-98
56. Ohno M, Watanabe S (1995) Persistent increase in dopamine release following activation of metabotropic glutamate receptors in the rat nucleus accumbens. Neurosci Lett 200:113-116
57. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, Orlando, Flo., USA
58. Pearl SM, Herrick-Davis K, Teitler M, Glick SD (1995) Radioligand-binding study of noribogaine, a likely metabolite of ibogaine. Brain Res 675:342-344
59. Plowchalk DR, Andersen ME, deBethizy JD (1992) A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat. Toxicol Appl Pharmacol 116: 177-188
60. 3H]MK-801 binding to the NMDA receptor complex. Psychopharmacology 114: 672-674
61. Ramoa AS, Alkondon M, Aracava Y, Irons J, Lunt GG, Deshpande SS, Wonnacott S, Aronstam RS, Albuquerque EX (1990) The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther 254:71-82
62. Sweetnam PM, Lancaster J, Snowman A, Collins JL, Perschke S, Bauer C, Ferkany J (1995) Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity. Psychopharmacology 118: 369-376
63. Taber MT, Fibiger HC (1995) Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J Neurosci 15:3896-3904
64. Varanda WA, Aracava Y, Sherby SM, VanMeter WG, Eldefrawi ME, Albuquerque EX (1985) The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a non-competitive antagonist. Mol Pharmacol 28: 128-137
65. Wang T, O'Connor WT, Ungerstedt U, French ED (1994) N-methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurons in the ventral tegmental area: in vivo microdialysis and in vitro electrophysiological studies. Brain Res 666:255-262
66. Yoshida M, Yokoo H, Tanaka T, Mizoguchi K, Emoto H, Ishii H, Tanaka M (1993) Facilitatory modulation of mesolimbic dopamine neuronal activity by a mu-opioid agonist and nicotine as examined with in vivo microdialysis. Brain Res 624:277-280